since 2018: Mildred-Scheel Professor on Computational Cancer Genomics (W2)
since 2013: Research group leader: Computational Cancer Genomics, University of Colgone
2012: Founder of Blackfield/ New Oncology AG, acquired by Siemens Healthcare in March 2016
2012 - 2013: Postdoc at the Department of Translational Genomics, University of Cologne (Roman Thomas).
2008 - 2012: Postdoc at the Max-Planck Institute for Neurological Research, Cologne (Roman Thomas).
2007 - 2008: Postdoc at the Institute of Chemistry of the Karl-Franzens- University Graz, Austria (Hans-Hennig von Grünberg).
2007 - 2007: Visiting scientist at Pennsylvania State University, U.S.A., Center for Comparative Genomics and Bioinformatics (Ross Hardison and Webb Miller).
2007: PhD in Physics at the Faculty of Mathematics and Physics of the Albert-Ludwigs University Freiburg, Germany. Title: ”Concepts from Non-Linear Dynamics and Statistical Physics Applied to Complex Networks in the Life Sciences”. Graduated with summa cum laude.
2003 - 2007: PhD in theoretical physics, University of Freiburg
2003: Diploma in Physics (equivalent to M.Sc.) at the Faculty of Mathematics and Physics of the Albert-Ludwigs University Freiburg, Germany. Topic: Nonparametric statistical methods applied to complex dynamical systems.
1996 - 2003: Physics studies, University of Freiburg
2018: Mildred-Scheel Professorship of the German Cancer Aid Member of the International Association for the Study of Lung Cancer, European Association for Cancer Research and Deutsche Physikalische Gesellschaft